Skip to main content
Livermore
Livermore
ZHEN

Cevian Capital II GP LTD

SEC CIK
0001365341
Latest filing
Aug 14, 2026

The latest 13F from Cevian Capital II GP LTD covers Q2 2026 (filed Aug 14, 2026): 3 long positions worth $3.70B. The top 10 holdings make up 100.0% of the portfolio, and the largest is UBS Group AG (UBS) at 64.5%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
0
Added
0
Reduced
1
Est. −$4.98M
Sold out
0

Top 5 holdings

Share of this quarter's portfolio value

  1. UBSUBS Group AG
    64.5%$2.38BHistory
  2. ALVAutoliv Inc
    19.8%$731.7MHistory
  3. CRHCRH Public Ltd Co
    15.7%$581.0MHistory

Share of portfolio

Each position's share of portfolio value

  1. UBS64.5%
  2. ALV19.8%
  3. CRH15.7%

Biggest buys

New and added positions, by estimated amount bought

None this quarter.

Largest weight increases

New and added positions, by percentage points of the portfolio gained

None this quarter.

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CRHCRH Public Ltd Co
    −$4.98MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. CRHCRH Public Ltd Co
    −2.75 pp18.5% → 15.7%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$3.70B
+$579.4M (+18.6%) vs. prior quarter
Positions
3
0 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
0.0%
Q2 2026, one quarter
Average holding period
13.3 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $4.00B (Q4 2023)

Q1 2021: $744.8MQ2 2021: $762.6MQ3 2021: $779.8MQ4 2021: $895.7MQ1 2022: $748.1MQ2 2022: $422.9MQ3 2022: $419.7MQ4 2022: $482.3MQ1 2023: $588.0MQ2 2023: $535.6MQ3 2023: $2.38BQ4 2023: $4.00BQ1 2024: $3.47BQ2 2024: $2.97BQ3 2024: $3.18BQ4 2024: $2.58BQ1 2025: $2.38BQ2 2025: $2.83BQ3 2025: $3.41BQ4 2025: $3.66BQ1 2026: $3.12BQ2 2026: $3.70B
Q1 2021Q2 2026
13F filings of Cevian Capital II GP LTD by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 20263$3.70BUBSALVCRHvs. Q1 2026SEC
Q1 2026May 15, 20263$3.12BUBSALVCRHvs. Q4 2025SEC
Q4 2025Feb 17, 20263$3.66BUBSALVCRHvs. Q3 2025SEC
Q3 2025Nov 14, 20253$3.41BUBSALVCRHvs. Q2 2025SEC
Q2 2025Aug 14, 20253$2.83BUBSALVCRHvs. Q1 2025SEC
Q1 2025May 15, 20253$2.38BUBSALVCRHvs. Q4 2024SEC
Q4 2024Feb 14, 20253$2.58BUBSCRHALVvs. Q3 2024SEC
Q3 2024Nov 14, 20243$3.18BUBSCRHALVvs. Q2 2024SEC
Q2 2024Aug 14, 20243$2.97BUBSCRHALVvs. Q1 2024SEC
Q1 2024May 15, 20243$3.47BCRHUBSALVvs. Q4 2023SEC
Q4 2023Feb 14, 20243$4.00BCRHUBSALVvs. Q3 2023SEC
Q3 2023Nov 14, 20232$2.38BCRHALVvs. Q2 2023SEC
Q2 2023Aug 14, 20231$535.6MALVvs. Q1 2023SEC
Q1 2023May 15, 20231$588.0MALVvs. Q4 2022SEC
Q4 2022Feb 14, 20231$482.3MALVvs. Q3 2022SEC
Q3 2022Nov 14, 20221$419.7MALVvs. Q2 2022SEC
Q2 2022Aug 15, 20221$422.9MALVvs. Q1 2022SEC
Q1 2022May 16, 20222$748.1MALVVNEvs. Q4 2021SEC
Q4 2021Feb 14, 20222$895.7MALVVNEvs. Q3 2021SEC
Q3 2021Nov 15, 20212$779.8MALVVNEvs. Q2 2021SEC
Q2 2021Aug 16, 20212$762.6MALVVNEvs. Q1 2021SEC
Q1 2021May 17, 20212$744.8MALVVNE–SEC

13D and 13G filings

Companies where Cevian Capital II GP LTD reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

3 companies, largest stake first.

Companies where Cevian Capital II GP LTD owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
PSOPearson PLC13D/A19.40%116.8M shares+0.23 ppfrom 19.17%Feb 1, 202112 filingsSep 23, 2026SEC
SNNSmith & Nephew PLC13D/A14.18%119.2M shares+1.09 ppfrom 13.09%Jul 9, 20249 filingsJul 27, 2026SEC
ALVAutoliv Inc13D/A12.02%9.32M shares–Aug 18, 20223 filingsMar 12, 2025SEC

Latest filings

25 filings on file made by Cevian Capital II GP LTD or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Cevian Capital II GP LTD
CompanyFiled (ET)FormStakeChangeEvent dateFiling
PSOPearson PLCSep 23, 20264:21 PM ET13D/A19.40%116.8M shares+0.23 ppfrom 19.17%Sep 22, 2026SEC
SNNSmith & Nephew PLCJul 27, 20265:00 PM ET13D/A14.18%119.2M shares+1.09 ppfrom 13.09%Jul 23, 2026SEC
SNNSmith & Nephew PLCJun 24, 20261:00 PM ET13D/A13.09%110.8M shares+1.21 ppfrom 11.88%Jun 22, 2026SEC
SNNSmith & Nephew PLCJun 3, 20261:00 PM ET13D/A11.88%101.0M shares+1.17 ppfrom 10.71%Jun 1, 2026SEC
SNNSmith & Nephew PLCMay 4, 20261:00 PM ET13D/A10.71%91.5M shares+1.11 ppfrom 9.60%Apr 30, 2026SEC
PSOPearson PLCApr 20, 202612:00 PM ET13D/A19.17%116.8M shares+1.03 ppfrom 18.14%Apr 16, 2026SEC
SNNSmith & Nephew PLCMar 16, 20262:40 PM ET13D/A9.60%81.7M shares+1.10 ppfrom 8.50%Mar 12, 2026SEC
PSOPearson PLCFeb 9, 20263:00 PM ET13D/A18.14%114.9M shares+1.51 ppfrom 16.63%Feb 5, 2026SEC
PSOPearson PLCFeb 2, 20263:08 PM ET13D/A16.63%105.7M shares+1.23 ppfrom 15.40%Jan 29, 2026SEC
PSOPearson PLCJan 16, 202612:30 PM ET13D/A15.40%97.9M shares+1.22 ppfrom 14.18%Jan 14, 2026SEC
PSOPearson PLCDec 8, 20253:43 PM ET13D/A14.18%90.2M shares+1.33 ppfrom 12.85%Dec 4, 2025SEC
SNNSmith & Nephew PLCJun 16, 202512:00 PM ET13D/A8.50%74.5M shares+1.01 ppfrom 7.49%Jun 12, 2025SEC
PSOPearson PLCApr 18, 202512:00 PM ET13D/A12.85%85.2M shares–Apr 17, 2025SEC
ALVAutoliv IncMar 12, 20251:00 PM ET13D/A12.02%9.32M shares–Mar 10, 2025SEC
SNNSmith & Nephew PLCFeb 19, 202512:04 PM ET13D/A7.49%65.5M shares+1.06 ppfrom 6.43%Feb 14, 2025SEC
SNNSmith & Nephew PLCDec 26, 20244:00 PM ET13D/A6.43%56.2M shares–Dec 20, 2024SEC
SNNSmith & Nephew PLCJul 9, 202413DOld format–New–SEC
ALVAutoliv IncAug 30, 202313D/AOld format–––SEC
PSOPearson PLCNov 14, 202213D/AOld format–––SEC
ALVAutoliv IncAug 18, 202213D/AOld format–––SEC